Compare Charles River Laboratories Intl. Inc (CRL) vs Flagstar Bank NA (FLG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Flagstar Bank NA — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Flagstar Bank NA trades at $11.32 (market cap $4.71B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 3× Flagstar Bank NA's market cap, and Flagstar Bank NA pays a 0.35% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Flagstar Bank NA for 22 Days on average.
| CRL | FLG | |
|---|---|---|
Market Cap | $14.23B | $4.71B |
Volume | 1,176,885 | 7,410,589 |
Sector | Health | Financials |
52-Week High | $310.77 | $15.36 |
52-Week Low | $149.93 | $10.72 |
Typical Hold Time | 33 Days | 22 Days |
Enterprise Value | $17.06B | $15.25B |
Dividend Yield | — | 0.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
Flagstar Bank (FLG) trades at $11.32, showing modest daily gains of 0.18%. The stock faces bearish technical signals with all moving averages indicating selling pressure, though oscillators are neutral. Fundamentally, the company reported a Q2 2026 earnings miss but maintains profitability with a net income margin of 2.3%. Recent developments include a strategic core banking partnership with Fiserv and a $250 million share repurchase program announced in July 2026.
Analyst consensus remains bullish with a $17.07 price target (60% buy ratings), suggesting significant upside potential. However, risks include recent earnings volatility, high P/E ratio of 378, and negative operating cash flow in 2025. The stock trades below book value (P/B 0.62), offering value opportunity if operational improvements continue.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →
